my best complete final answer to the task.

### Epidemiology of Lymphoma

#### Incidence and Prevalence
1. **Incidence**:
   - **Hodgkin Lymphoma (HL)**: The incidence of HL is relatively low, with about 2.7 cases per 100,000 people annually in the United States. It is more common among younger individuals, particularly those aged 15 to 35, and also sees a smaller peak in older adults aged 55 and above.
   - **Non-Hodgkin Lymphoma (NHL)**: NHL is more prevalent than HL, with an incidence rate of approximately 19.6 cases per 100,000 people annually in the United States. The incidence increases with age, with the majority of cases occurring in individuals aged 60 and above.

2. **Prevalence**:
   - The prevalence of lymphoma varies globally, influenced by geographic, environmental, and genetic factors. In the United States, the prevalence of NHL is significantly higher than that of HL. According to the Surveillance, Epidemiology, and End Results (SEER) database, the estimated number of people living with NHL in 2018 was about 761,659, while those living with HL were approximately 196,039.

#### High-Risk Populations
1. **Age**:
   - **HL**: Predominantly affects younger adults (15-35 years) and shows a second peak in older adults (55 years and above).
   - **NHL**: Incidence increases with age, with most cases diagnosed in individuals aged 60 and older.

2. **Gender**:
   - Both HL and NHL are slightly more common in males than females.

3. **Geography**:
   - Higher incidence rates of NHL are observed in developed countries compared to developing countries. However, certain subtypes, such as Burkitt lymphoma, are more common in specific geographic regions like equatorial Africa.

4. **Ethnicity**:
   - NHL is more common in Caucasians than in African Americans or Asians.

#### Risk Factors and Causes
1. **Genetic Factors**:
   - Family history of lymphoma or other hematologic malignancies increases the risk of developing lymphoma.
   - Certain genetic syndromes, such as Wiskott-Aldrich syndrome, ataxia-telangiectasia, and Klinefelter syndrome, are associated with a higher risk of lymphoma.

2. **Infections**:
   - **Epstein-Barr Virus (EBV)**: Strongly associated with certain types of HL and NHL, such as Burkitt lymphoma and some cases of diffuse large B-cell lymphoma (DLBCL).
   - **Human Immunodeficiency Virus (HIV)**: Increases the risk of NHL, particularly aggressive subtypes like primary central nervous system lymphoma.
   - **Helicobacter pylori**: Linked to mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach.
   - **Human T-cell lymphotropic virus (HTLV-1)**: Associated with adult T-cell leukemia/lymphoma.

3. **Immunosuppression**:
   - Individuals with weakened immune systems, whether due to congenital conditions, organ transplantation, or immunosuppressive medications, are at higher risk for NHL.

4. **Environmental Factors**:
   - Exposure to certain chemicals, such as pesticides, herbicides, and solvents, has been linked to an increased risk of lymphoma.
   - Radiation exposure, particularly at high doses, increases the risk of both HL and NHL.

5. **Autoimmune Diseases**:
   - Conditions such as rheumatoid arthritis, systemic lupus erythematosus, and Sj√∂gren syndrome are associated with an increased risk of NHL.

### Conclusion
Lymphoma encompasses a diverse group of malignancies with varying incidence and prevalence rates. Hodgkin lymphoma predominantly affects younger and older adults, whereas non-Hodgkin lymphoma is more common in older populations. Various genetic, environmental, and infectious factors contribute to the risk of developing lymphoma. Understanding the epidemiology of lymphoma is crucial for identifying at-risk populations and implementing effective prevention and early detection strategies.